Jose Merino, ESC 2018 – Idiopathic Ventricular Tachycardia and Premature Ventricular Complexes

Dr Jose L Merino (Director, Arrhythmia-Electrophysiology Research Unit, Hospital General Universitario La Paz, Madrid, Spain) discusses the current challenges, treatment options, unmet clinical needs and recurrence rate for idiopathic ventricular tachycardia (VT) and premature ventricular complexes (PVC). Part 1 of 3.

Filmed at ESC 2018, Munich.

View more content here.

Speaker Disclosure: Dr Jose L Merino has the following disclosures in relation to this video interview: Abbott: educational contracts, advisory board, research contracts, speaker fees. Biosense: educational contracts. Biotronik: advisory board, research contracts. Boston Scientific: advisory board, fellows grants. Medtronic: fellows grants.

Questions:

Part 1:

1. What are the current challenges of treating patients with idiopathic ventricular tachycardia (VT) and premature ventricular complexes (PVC)? (0:09)

Part 2:

2. How do you identify the patients most at risk of VT and PVC? (0:09)

3. What recent progress has been made in the treatment options for patients with VT and PVC? (1:29)

Part 3:

4. What are the current unmet clinical needs for identifying and treating patients with VT and PVC? (0:09)

5. What is the recurrence rate for VT and PVC following successful treatment via medication or ablation? (2:11)

touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.